Status:
WITHDRAWN
A Survey to Evaluate the Rate of Abnormal Glucose Tolerance Among Hong Kong Chinese Subjects With Coronary Heart Disease
Lead Sponsor:
Chinese University of Hong Kong
Conditions:
Coronary Heart Disease
Diabetes Mellitus
Eligibility:
All Genders
18+ years
Brief Summary
Hypothesis: there is a high prevalence rate of diabetes, including asymptomatic undiagnosed glucose intolerance, among subjects with coronary heart disease in Hong Kong. A cross-sectional survey is p...
Detailed Description
Diabetes is becoming an epidemic in Hong Kong, affecting over 10% of population and causing a major burden to the health care system. Over 30-40% of patients admitted to the medical wards of the Hospi...
Eligibility Criteria
Inclusion
- Patients aged 18 years
- Subjects admitted to Hospital Authority hospital as in-patients (AHNH) with the diagnosis of coronary heart disease (ICD code 410-414) during the period 1 April 2007 to 31 March 2008.
- Subjects admitted to AHNH for the procedure Percutaneous Coronary Intervention (PCI) to manage coronary heart disease.
Exclusion
- Known Type 1 diabetes defined as history of ketosis \[acute symptoms with heavy ketonuria (\>3+) or ketoacidosis\] or heavy ketonuria (3+) or continuous requirement of insulin treatment within one year of diagnosis and thereafter.
- Patients with terminal malignancy or other life-threatening diseases with less than 6-month expected survival
- Patients with a mental condition rendering the subject unable to understand the nature, scope, and possible consequences of the study
Key Trial Info
Start Date :
October 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2018
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00786175
Start Date
October 1 2008
End Date
December 1 2018
Last Update
August 24 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hong Kong Institute of Diabetes and Obesity
Hong Kong, China